Organophosphate-induced	organophosphate-induced	O	O
convulsions	convulsions	O	S_disease
and	and	O	O
prevention	prevention	O	O
of	of	O	O
neuropathological	neuropathological	O	O
damages	damages	O	O
.	.	O	O

Such	such	O	O
organophosphorus	organophosphorus	S_chemicals	O
(	(	O	O
OP	op	O	O
)	)	O	O
compounds	compounds	O	O
as	as	O	O
diisopropylfluorophosphate	diisopropylfluorophosphate	S_chemicals	O
(	(	O	O
DFP	dfp	S_chemicals	O
)	)	O	O
,	,	O	O
sarin	sarin	S_chemicals	O
and	and	O	O
soman	soman	S_chemicals	O
are	are	O	O
potent	potent	O	O
inhibitors	inhibitors	O	O
of	of	O	O
acetylcholinesterases	acetylcholinesterases	O	O
(	(	O	O
AChEs	aches	O	S_disease
)	)	O	O
and	and	O	O
butyrylcholinesterases	butyrylcholinesterases	O	O
(	(	O	O
BChEs	bches	O	O
)	)	O	O
.	.	O	O

The	the	O	O
acute	acute	O	O
toxicity	toxicity	O	O
of	of	O	O
OPs	ops	O	O
is	is	O	O
the	the	O	O
result	result	O	O
of	of	O	O
their	their	O	O
irreversible	irreversible	O	O
binding	binding	O	O
with	with	O	O
AChEs	aches	O	S_disease
in	in	O	O
the	the	O	O
central	central	O	B_disease
nervous	nervous	O	B_disease
system	system	O	I_disease
(	(	O	O
CNS	cns	O	O
)	)	O	O
,	,	O	O
which	which	O	O
elevates	elevates	O	O
acetylcholine	acetylcholine	S_chemicals	O
(	(	O	O
ACh	ach	S_chemicals	O
)	)	O	O
levels	levels	O	O
.	.	O	O

The	the	O	O
protective	protective	O	O
action	action	O	O
of	of	O	O
subcutaneously	subcutaneously	O	O
(	(	O	O
SC	sc	O	O
)	)	O	O
administered	administered	O	O
antidotes	antidotes	S_chemicals	O
or	or	O	O
their	their	O	O
combinations	combinations	O	O
in	in	O	O
DFP	dfp	S_chemicals	O
(	(	O	O
2.0	2.0	O	O
mg/kg	mg/kg	O	O
BW	bw	O	O
)	)	O	O
intoxication	intoxication	O	O
was	was	O	O
studied	studied	O	O
in	in	O	O
9	9	O	O
-	-	O	O
10-weeks-old	10-weeks-old	O	O
Han-Wistar	han-wistar	O	O
male	male	O	O
rats	rats	O	O
.	.	O	O

The	the	O	O
rats	rats	O	O
received	received	O	O
AChE	ache	O	S_disease
reactivator	reactivator	O	O
pralidoxime-2-chloride	pralidoxime-2-chloride	O	O
(	(	O	O
2PAM	2pam	O	O
)	)	O	O
(	(	O	O
30.0	30.0	O	O
mg/kg	mg/kg	O	O
BW	bw	O	O
)	)	O	O
,	,	O	O
anticonvulsant	anticonvulsant	S_chemicals	O
diazepam	diazepam	S_chemicals	O
(	(	O	O
2.0	2.0	O	O
mg/kg	mg/kg	O	O
BW	bw	O	O
)	)	O	O
,	,	O	O
A(1)-adenosine	a(1)-adenosine	O	O
receptor	receptor	B_chemicals	O
agonist	agonist	I_chemicals	O
N(6)-cyclopentyl	n(6)-cyclopentyl	O	O
adenosine	adenosine	O	O
(	(	O	O
CPA	cpa	O	O
)	)	O	O
(	(	O	O
2.0	2.0	O	O
mg/kg	mg/kg	O	O
BW	bw	O	O
)	)	O	O
,	,	O	O
NMDA-receptor	nmda-receptor	O	O
antagonist	antagonist	O	O
dizocilpine	dizocilpine	O	O
maleate	maleate	O	O
(	(	B_chemicals	O
+	+	I_chemicals	O
-MK801	-mk801	O	O
hydrogen	hydrogen	B_chemicals	O
maleate	maleate	I_chemicals	O
)	)	O	O
(	(	O	O
2.0	2.0	O	O
mg/kg	mg/kg	O	O
BW	bw	O	O
)	)	O	O
or	or	O	O
their	their	O	O
combinations	combinations	O	O
with	with	O	O
cholinolytic	cholinolytic	S_chemicals	O
drug	drug	S_chemicals	O
atropine	atropine	B_chemicals	O
sulfate	sulfate	S_chemicals	O
(	(	O	O
50.0	50.0	O	O
mg/kg	mg/kg	O	O
BW	bw	O	O
)	)	O	O
immediately	immediately	O	O
or	or	O	O
30	30	O	O
min	min	O	O
after	after	O	O
the	the	O	O
single	single	O	O
SC	sc	O	O
injection	injection	O	O
of	of	O	O
DFP	dfp	S_chemicals	O
.	.	O	O

The	the	O	O
control	control	O	O
rats	rats	O	O
received	received	O	O
atropine	atropine	B_chemicals	O
sulfate	sulfate	S_chemicals	O
,	,	O	O
but	but	O	O
also	also	O	O
saline	saline	O	O
and	and	O	O
olive	olive	B_chemicals	O
oil	oil	I_chemicals	O
instead	instead	O	O
of	of	O	O
other	other	O	O
antidotes	antidotes	S_chemicals	O
and	and	O	O
DFP	dfp	S_chemicals	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

All	all	O	O
rats	rats	O	O
were	were	O	O
terminated	terminated	O	O
either	either	O	O
24	24	O	O
h	h	O	O
or	or	O	O
3	3	O	O
weeks	weeks	O	O
after	after	O	O
the	the	O	O
DFP	dfp	S_chemicals	O
injection	injection	O	O
.	.	O	O

The	the	O	O
rats	rats	O	O
treated	treated	O	O
with	with	O	O
DFP-atropine	dfp-atropine	O	O
showed	showed	O	O
severe	severe	O	O
typical	typical	O	O
OP-induced	op-induced	O	O
toxicity	toxicity	O	O
signs	signs	O	O
.	.	O	O

When	when	O	O
CPA	cpa	O	O
,	,	O	O
diazepam	diazepam	S_chemicals	O
or	or	O	O
2PAM	2pam	O	O
was	was	O	O
given	given	O	O
immediately	immediately	O	O
after	after	O	O
DFP-atropine	dfp-atropine	O	O
,	,	O	O
these	these	O	O
treatments	treatments	O	O
prevented	prevented	O	O
,	,	O	O
delayed	delayed	O	O
or	or	O	O
shortened	shortened	O	O
the	the	O	O
occurrence	occurrence	O	O
of	of	O	O
serious	serious	O	O
signs	signs	O	O
of	of	O	O
poisoning	poisoning	O	S_disease
.	.	O	O

Atropine-MK801	atropine-mk801	O	O
did	did	O	O
not	not	O	O
offer	offer	O	O
any	any	O	O
additional	additional	O	O
protection	protection	O	O
against	against	O	O
DFP	dfp	S_chemicals	O
toxicity	toxicity	O	O
.	.	O	O

In	in	O	O
conclusion	conclusion	O	O
,	,	O	O
CPA	cpa	O	O
,	,	O	O
diazepam	diazepam	S_chemicals	O
and	and	O	O
2PAM	2pam	O	O
in	in	O	O
combination	combination	O	O
with	with	O	O
atropine	atropine	O	O
prevented	prevented	O	O
the	the	O	O
occurrence	occurrence	O	O
of	of	O	O
serious	serious	O	O
signs	signs	O	O
of	of	O	O
poisoning	poisoning	O	S_disease
and	and	O	O
thus	thus	O	O
reduced	reduced	O	O
the	the	O	O
toxicity	toxicity	O	O
of	of	O	O
DFP	dfp	S_chemicals	O
in	in	O	O
rat	rat	O	O
.	.	O	O

